Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 247 clinical trials
LimPrOn: Limburg Pre-eclampsia Investigation (LimPrOn)

Background Multiple adaptations at the cardiovascular system occurs during pregnancy. In the pregnancy condition pre-eclampsia (PE), this adaptations are abnormal

eclampsia
proteinuria
Accepts healthy volunteers
prenatal
toxemia of pregnancy
  • 43 views
  • 03 Mar, 2022
  • 8 locations
Screening for Cancer in Patients With Unprovoked VTE

Open and multicenter randomized clinical trial (1:1) comparing limited screening with extended screening with the performance of Positron emission tomography-computed tomography (PET-CT) scan in the search for neoplasms in patients with unprovoked venous thromboembolic disease at high risk of developing cancer at follow-up. Introduction: Cancer screening in patients with unprovoked …

venous thromboembolic disease
clot
deep vein thrombosis
cancer
embolism
  • 0 views
  • 18 Dec, 2021
  • 9 locations
API-CAT STUDY for APIxaban Cancer Associated Thrombosis (API-CAT)

incidental) or pulmonary embolism (symptomatic or incidental).

  • 33 views
  • 24 Jul, 2022
  • 71 locations
Statins for Venous Event Reduction in Patients With Venous Thromboembolism (SAVER)

The standard or usual treatment for patients diagnosed with deep vein thrombosis or pulmonary embolism is treatment with blood thinners (called anticoagulants). While treatment of blood

blood clot
embolism
thromboembolism
thrombosis
rosuvastatin
  • 0 views
  • 22 Mar, 2022
  • 7 locations
Use of Probiotics to Reduce Infections, Death and ESBL Colonisation (ProRIDE)

This study examines the effect of oral probiotic treatment to newborns on preventing hospitalizations, death and colonization with Extended-spectrum beta-lactamase-producing Gram negative bacteria. Half of the babies will receive 4 weeks treatment with an oral mixture of the probiotic Labinic (R) while the other half will receive a placebo mixture.

Accepts healthy volunteers
  • 0 views
  • 26 Apr, 2022
  • 1 location
REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. (RENOVE)

Patients with unprovoked venous thromboembolism (VTE) or VTE associated with persistent risk factors have a high risk of recurrence after stopping anticoagulation. In these patients, international guidelines recommend indefinite anticoagulation. However, prolonged use of warfarin or DOAC at therapeutic dose is associated with a significant risk of bleeding. Consequently, it …

anticoagulation therapy
rivaroxaban
apixaban 2.5 mg
apixaban
aspirin
  • 7 views
  • 03 May, 2022
  • 26 locations
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer from non-valvular atrial fibrillation (AF). In this particular setting, balancing between the prevention of thrombosis and the risk of bleeding remains challenging. Oral anticoagulation (OAC) prevents stroke and …

stemi
bypass graft
fibrillation
dabigatran
embolism
  • 0 views
  • 12 Nov, 2021
  • 1 location
COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation

The primary objective is to prove non-inferiority of thermal ablation compared to hepatic resection in patients with at least one resectable and ablatable colorectal liver metastases (3cm) and no extrahepatic disease.

liver metastasis
metastasis
  • 33 views
  • 23 Jan, 2021
  • 2 locations
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial (HeLiX)

This is a Phase III multicentre randomized controlled trial (RCT) to evaluate the impact of tranexamic acid (TXA) on perioperative blood transfusion in patients undergoing liver resection. The rationale for this study includes: (1) experimental evidence supporting the use of TXA in other surgical populations; (2) lack of evidence in …

cancer
liver surgery
primary cancer
blood transfusion
  • 17 views
  • 23 Mar, 2022
  • 10 locations
Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER) (FibER)

Fibrinogen replacement could prevent haemorrhagic complications in ischemic stroke patients with secondary post-rtPA hypofibrinogenemia

stroke
fibrinogen
  • 0 views
  • 20 Apr, 2022
  • 1 location